October 30, 2017

Several whistleblowers will receive a portion of the $75 million Ohio-based Chemed Corporation and various wholly-owned subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, agreed to pay to resolve charges they violated the False Claims Act by submitting claims for hospice services to Medicare for patients not terminally ill. DOJ

Tagged in: FCA Federal, Home Health and Hospice, Lack of Medical Necessity, Whistleblower Case,